Ole Vahlgren

Ole Vahlgren is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chairman of the Board and Board Member at Blue Cell Therapeutics, and Chief Executive Officer at AJ Vaccines, Vahlgren has demonstrated leadership in creating high-quality vaccine solutions. Previous roles include President & CEO of Otsuka Pharmaceutical Europe Ltd., where Vahlgren revitalized operations and established new business units across Europe, and Global Head and Senior Vice President of Corporate Business Development & Strategy at Lundbeck, where Vahlgren spearheaded significant partnerships and acquisitions, significantly expanding the company's global presence. Vahlgren also served as Managing Director at Gramineer AB, transforming the company into a focused biomedical R&D entity. Vahlgren holds an M.B.A. from Copenhagen Business School and a Master’s Degree in Electrical and Electronics Engineering from the Technical University of Denmark.